Infogenetica's story really begins when Alma and Deryck were blessed with a pair of fraternal twin sons. They were overjoyed by their arrival, but within the first year of their sons' lives, they realized that something was different with one of the boys.
He never made eye contact and was always uneasy. He was overly sensitive to sound, light, scents, and textures. He didn't respond to people talking to him and would get over-fixated on specific items. In spite of very early interventions with pediatricians and occupational, behavioural, and speech therapists things kept getting worse as time went by.
He developed very obvious persevering behaviours and ticks, had significant fine and gross motor skills problems, an awkward gait, upper right limb spasticity, and didn't speak at all. He didn't play appropietly with toys nor was interested in any social interactions. He was still in diapers up to age 5, was very hyperactive, had frequent emotional outbursts, and couldn't control his behaviour. He also showed no reaction to pain, the slightest changes in routine would cause a meltdown, and couldn't sleep through the night without medication.
Alma, Deryck, and 5-year-old twins.
By the age of 4, he was officially diagnosed with Autism Spectrum Disorder (ASD), Attention Deficit and Hyperactivity Disorder (ADHD), severe Sensory Processing Disorder (SPD), developmental delays, and metopic and sagittal craniosynostosis (the premature fusion of the skull sutures, which was compressing his brain, causing injury.) The prognosis given by the specialists was tragic. They predicted that he would never be able to take care of even his most basic needs by himself, would never talk or have any meaningful social interaction. These were overwhelming news for Alma and Deryck and, at the time, there was almost no additional information or support for families with autistic children beyond the diagnosis.
He also required skull reconstructive surgery to address the craniosynostosis and would need 24/7 supervision and one-to-one care for a year while his skull recovered. At that moment, Deryck made a major professional decision and left his job at BC Cancer to care for his son and focus all his research efforts on autism. Putting it in his own words: what was the point of spending his life working on a cure for cancer if he couldn't help his own son to have a better life with his condition.
The skull surgery was successful and had a significant positive effect on his fine and gross motor skills and his reaction to pain became normal. However, even after a year from the surgery and constant behavioural, occupational, and speech therapies, pediatric and psychiatric care, all the typical autism symptoms remained the same, showing no response to any of the many therapies.
During this time, Deryck started his research on autism and the different biological pathways that seemed to be affected by the autism symptoms. Drawing from some of the research he did on Alzheimer's while working in the pharmaceutical industry, Deryck identified that the lack of sleep, inability to focus, anxiety, lack of speech, hyperactivity, gastric and skin problems, sudden outbursts and lack of energy, impulsive behaviour, etc. all involved pathways that required fatty acids for proper function.
Given his deep knowledge of fatty acids, Deryck knew that he needed to give his son a supplement that comprised a balanced and customized formulation of fatty acids. Also, he needed to avoid artificial preservatives and flavours given that his son was very sensitive to these. In spite of extensive market research, he found out there was only at most Omega 3-6-9, a very small fraction of the complete combination of fatty acids needed. There was no product available in the market that met all his requirements. So he decided to develop himself an optimized fatty acid composition made up of 100% natural ingredients, without GMOs, artificial flavours, or preservatives. That was what gave birth to the formulation that, after several years of research and optimization, would lead to NeuroActiv™ Oil.
The effects of a daily dosage of NeuroActiv™ Oil in conjunction with a gluten-free, mostly-unprocessed diet and educational programs have been remarkable for Deryck's and Alma's son. Twelve years after starting to take the supplement, he is now categorized within the high-functioning end of the autism spectrum. He talks, reads, socializes, and cares for his own personal hygiene, homework, and house chores. He is calmer, more focused, and has a lot less obsessive behaviours and phobias. His energy level is more consistent throughout the day. He attended the same schools as his twin brother, taking the same subjects in an adapted program. He sleeps through the night without the need for medication and is a loving and joyful teenager. He even made it on the Honor Roll in grade 10! He has participated in the school choir and church programs and engages people in social conversation. He is an artist and graduated from high school. He took an entrepreneurial program last year and he will soon be launching an online store to sell his art.
Samples of our son's art - decorative wall sign and clay dinosaur egg figurine.
Twins' high school graduation
People who noticed this remarkable improvement started enquiring about the supplement and started trying it for themselves. After consistent positive feedback and regular reports of general health improvement from friends and family who have suffered from low energy, poor sleep, high cholesterol, joint problems, poor memory, lack of focus, poor skin or hair quality, etc., Alma and Deryck decided to share it with others. After almost 8 more years of research, numerous tests, patenting the formulation and obtaining Health Canada authorization to sell NeuroActiv™ Oil, Infogenetica Solutions Ltd. was formed.